Friday 6 November 2026 Export BTAIQ’s income statement to Excel — free account

BioXcel Therapeutics, Inc.

BTAIQ Healthcare Drug Manufacturers Specialty & Generic

BioXcel Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $642,000.00, down 71.7% from fiscal 2024.

Revenue: +51.7%
EPS: +80.0%
Free cash flow: +51.5%
Total debt: −3.90%

Quarter to June 2026, against a year earlier

0.01 0.00 0.00%

Follow BTAIQ

Alert me

Market cap: $2.3M
P/E: 0.0×
Fwd P/E: −0.4×
Dividend yield: —
F-score: 2/9
Altman Z: −26.30
Beneish M: −0.61
Dividend safety: n/a

Overview

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	2	2	1	+8 more TTM periods Free account
ROE Full definition →	63.52%	76.98%	74.14%	78.16%
ROA Full definition →	(259.62%)	(207.56%)	(167.91%)	(145.62%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	65.40%	359.26%	770.98%	(996.07%)
Average Days of Receivables Full definition →	40.34	115.94	132.47	0.00
Free Cash Flow per Share Full definition →	(1.68)	(2.43)	(4.72)	(4.10)
Free Cash Flow Full definition →	(50.90)	(57.38)	(57.61)	(58.21)
Other line items
Cash ROIC Full definition →	(1,823.21%)	(481.14%)	(134.34%)	(101.20%)
Accounts Receivable Turnover Full definition →	6.97	6.21	1.23	0.00
Accounts Payable Turnover Full definition →	0.02	0.03	0.01	0.06
Inventory Turnover Full definition →	0.70	0.76	0.23	0.97
Average Days of Payables Full definition →	19,700.56	13,695.51	32,718.69	6,168.99
Days of Inventory on Hand Full definition →	506.59	421.48	1,606.89	173.97
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	2,905.66%	4,213.53%	4,711.99%	3,916.36%
Selling, General and Administrative Expense of Revenue Full definition →	3,176.01%	3,233.24%	3,192.21%	2,763.83%
Share Based Compensation of Revenue Full definition →	245.82%	444.41%	431.00%	281.65%
Interest Coverage Full definition →	(2.61)	(2.94)	(2.97)	(3.05)
Operating CF/Net income Full definition →	0.72	0.76	0.82	0.85
Depreciation/Fixed assets Full definition →	2.27	2.41	1.71	1.22
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.02	0.03	0.05	0.05
Operating CF per Share Full definition →	(1.68)	(2.43)	(4.72)	(4.10)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly